ACCELON
LIVE

Serial Number

87112018

Owner

BASF AS

Attorney

Sarah M. Robertson

First Use Date

Apr 23, 2019

Filing Date

Jul 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ACCELON Trademark

Serial Number: 87112018 • Registration: 6356164

ACCELON is a trademark filed by BASF AS on July 21, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BASF AS (17 trademarks)

Lilleakerveien 2C

Entity Type: 16

Pronova Biopharma Norge AS

Lilleakerveien 2 C
Oslo , NO

Entity Type: 99

Trademark Details

Filing Date

July 21, 2016

Registration Date

May 18, 2021

First Use Anywhere

April 23, 2019

First Use in Commerce

April 23, 2019

Published for Opposition

June 20, 2017

Goods & Services

Excipients for use in the manufacture of pharmaceutical preparations and/or dietary supplements

Excipients sold as an ingredient of dietary and nutritional supplements; excipients sold as an ingredient of dietary and nutritional supplements for endurance sports; excipients sold as an ingredient of medicinal oils; excipients sold as an ingredient of dietetic foods, namely, omega 3 capsules, tablets, gels, chewables, smoothies, enteral feed formulas, liquid nutritive preparations for oral or tube feeding and nutritional bars with omega-3 formulation, adapted for medical purposes; excipients sold as an ingredient of biological preparations for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic beverages adapted for nutritional support for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic substances, namely, omega-3 concentrate adapted for medical use; excipients sold as an ingredient of nutritional supplements adapted for medical use; excipients sold as an ingredient of nutritional supplements; excipients sold as an ingredient of food supplements for medical purposes

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 18, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 14, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 13, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2021 CRFA
ASSIGNED TO LIE
Feb 4, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 17, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 2, 2020 SUPC
USE AMENDMENT FILED
Jun 1, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 1, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2020 EXRA
SOU EXTENSION 5 GRANTED
Feb 26, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 26, 2020 AITU
SOU EXTENSION 5 FILED
Feb 18, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 18, 2020 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 13, 2019 ASGN
PETITION TO DIRECTOR DENIED
Oct 18, 2019 PCDE
ASSIGNED TO PETITION STAFF
Oct 15, 2019 APET
TEAS PETITION TO DIRECTOR RECEIVED
Sep 25, 2019 TPDR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2019 EXRA
SOU EXTENSION 4 GRANTED
Aug 14, 2019 EX4G
SOU EXTENSION 4 FILED
Aug 14, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 14, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2019 EXRA
SOU EXTENSION 3 GRANTED
Jan 23, 2019 EX3G
SOU EXTENSION 3 FILED
Jan 23, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 23, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 8, 2018 EXRA
SOU EXTENSION 2 GRANTED
Aug 6, 2018 EX2G
SOU EXTENSION 2 FILED
Aug 6, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 6, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2018 EXRA
SOU EXTENSION 1 GRANTED
Feb 6, 2018 EX1G
SOU EXTENSION 1 FILED
Feb 6, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 6, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 15, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 20, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 20, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 31, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
May 9, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 9, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
May 9, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 9, 2017 CNEA
EXAMINER'S AMENDMENT ENTERED
May 9, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 9, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
May 9, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 9, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 12, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 12, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 12, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2016 NWOS
NEW APPLICATION ENTERED
Jul 25, 2016 NWAP